|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/22/22 Nymox Pharmaceutical Corp. 424B5 1:117K Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 424B5 Prospectus - Primary Offering or Shelf Securities HTML 77K
- New Facts or Events
| Original SGML Text submitted by: | Pubco Reporting Solutions, Inc./FA (as Filing Agent) |
|---|
<SUBMISSION> <SECRELEASE-DATETIME> 20220322-145729 ⇐ Metadata from SEC Info (ET) <SECWEBSITE-DATETIME> 20220322-145657 ⇐ Metadata from SEC Info (ET) <ACCEPTANCE-DATETIME> 20220322-145610 ⇐ Filing accepted by SEC (ET) <ACCESSION-NUMBER> 0001640334-22-000556 <TYPE> 424B5 <PUBLIC-DOCUMENT-COUNT> 2 <FILING-DATE> 20220322 <DATE-OF-FILING-DATE-CHANGE> 20220322 |
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> NYMOX PHARMACEUTICAL CORP
<CIK> 0001018735
<ASSIGNED-SIC> 2835
<IRS-NUMBER> 000000000
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 424B5
<ACT> 33
<FILE-NUMBER> 333-261571
<FILM-NUMBER> 22759013
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 9900 CAVENDISH BLVD., SUITE 306
<STREET2> ST. LAURENT
<CITY> QUEBEC CANADA
<STATE> A8 ⇐ This is an SEC Country/Territory Code for
Quebec, Canada {CA|CAN}
<ZIP> H4M 2V2
<PHONE> 1-800-936-9669
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 9900 CAVENDISH BLVD., SUITE 306
<STREET2> ST. LAURENT
<CITY> QUEBEC CANADA
<STATE> A8 ⇐ This is an SEC Country/Territory Code for
Quebec, Canada {CA|CAN}
<ZIP> H4M 2V2
</MAIL-ADDRESS>
</FILER>
|
<DOCUMENT> <TYPE> 424B5 <SEQUENCE> 1 <FILENAME> nymox_424b5.htm <DESCRIPTION> 424B5 <TEXT> <html> Show <HTML>: 1 lines (widest: 114,388 characters) - 112K bytes </TEXT> </DOCUMENT> |
<DOCUMENT> <TYPE> GRAPHIC <SEQUENCE> 2 ⇐ Not a Document/Exhibit <FILENAME> nymox_424b5img1.jpg <TEXT> Show <TEXT>: 69 lines (Unix-to-Unix encoding) - 5K bytes </TEXT> </DOCUMENT> |
</SUBMISSION> |
| ↑Top |